Eli Lilly's Alzheimer's treatment approved in China
(Reuters) - China's medical regulator has approved Eli Lilly (NYSE:LLY)'s treatment for early Alzheimer's, providing patients with another option after Eisai and Biogen...
(Reuters) - China's medical regulator has approved Eli Lilly (NYSE:LLY)'s treatment for early Alzheimer's, providing patients with another option after Eisai and Biogen...
-- LKQ Corporation (NASDAQ:LKQ), a leading name in the automotive aftermarket is emerging as a compelling play for 2025, thanks to a strategic shift toward...
-- Australia's Insignia Financial has rejected a A$2.67 billion ($1.69 billion) takeover bid from Bain Capital, saying the offer does not provide fair value to its...
By Jarrett Renshaw, Rachael Levy and Chris Kirkham (Reuters) - The Trump transition team wants the incoming administration to drop a car-crash reporting requirement opposed by...
By David Shepardson WASHINGTON (Reuters) -The U.S. Transportation Department on Tuesday finalized its awards of five new daily round-trip flights from Washington Reagan National...
-- Eli Lilly and Company (NYSE:LLY) said on Tuesday evening that China’s food and drug regulator had approved its Kisunla treatment for early symptomatic Alzheimer's...
-- Shares of Nissan) and Mitsubishi Motors)rose sharply on Wednesday after media reports said Honda and Nissan (OTC:NSANY) were considering a three-way merger in the...
-- Stifel downgraded its rating on Electronic Arts Inc (NASDAQ:EA), stating that while the stock did mark strong returns in 2024, it was likely to see limited upside...
TOKYO (Reuters) - Bain Capital plans to launch a tender offer for Fuji Soft shares even without the approval of the target firm's board of directors, the U.S. private equity firm...
By Luc Cohen NEW YORK (Reuters) -Luigi Mangione sought to "sow terror" by shooting dead UnitedHealth Group (NYSE:UNH) executive Brian Thompson on a Manhattan street this month, a...